Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme targets, enhancing drug efficacy. Commonly employed in medicinal chemistry for constructing bioactive molecules due to the stability and metabolic resistance provided by the difluorocyclopropyl group. Also utilized in agrochemical research for designing novel pesticides with improved activity and environmental profiles.